Oxford BioMedica (OXBDF) News Today $7.35 0.00 (0.00%) As of 09/2/2025 Add Compare Share Share Headlines Stock AnalysisChartHeadlinesShort InterestBuy This Stock OXBDF Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Oxford Biomedica price target raised to 930 GBp from 800 GBp at RBC CapitalAugust 26, 2025 | msn.comOxford BioMedica (OTCMKTS:OXBDF) Reaches New 12-Month High - Should You Buy?August 23, 2025 | marketbeat.comOxford Biomedica Director’s Share Transaction Error and ResolutionAugust 22, 2025 | tipranks.comOxford BioMedica (OTCMKTS:OXBDF) Sets New 1-Year High - Here's What HappenedAugust 17, 2025 | marketbeat.comOxford Biomedica’s Chair Increases Stake with Significant Share PurchaseAugust 15, 2025 | msn.comOxford BioMedica raises GBP60 million to fund US expansionAugust 15, 2025 | lse.co.ukOxford Biomedica Raises £60 Million to Expand US OperationsAugust 15, 2025 | tipranks.comOxford BioMedica (OTCMKTS:OXBDF) Shares Gap Down - Should You Sell?August 14, 2025 | marketbeat.comOxford BioMedica (OTCMKTS:OXBDF) Trading Down 0.6% - Here's WhyAugust 14, 2025 | marketbeat.comOxford BioMedica (OTCMKTS:OXBDF) Reaches New 1-Year High - Still a Buy?August 6, 2025 | marketbeat.comOxford BioMedica (OTCMKTS:OXBDF) Hits New 52-Week High - Time to Buy?July 31, 2025 | marketbeat.comOxford BioMedica holds outlook as revenue jumps and order book boostedJuly 28, 2025 | lse.co.ukUK's Oxford Biomedica sees first-half sales surging on strong order bookJuly 28, 2025 | reuters.comUK's Oxford Biomedica maintains annual outlookJuly 28, 2025 | reuters.comOxford BioMedica (OTCMKTS:OXBDF) Shares Gap Down - What's Next?July 21, 2025 | marketbeat.comOxford BioMedica (OTCMKTS:OXBDF) Shares Gap Up - Should You Buy?July 18, 2025 | marketbeat.comOxford BioMedica (OTCMKTS:OXBDF) Trading Up 2.6% - Still a Buy?July 11, 2025 | marketbeat.comOxford BioMedica completes purchase of last 10% stake in US subsidiaryJune 23, 2025 | lse.co.ukOxford BioMedica (OTCMKTS:OXBDF) Trading Down 8.2% - What's Next?June 19, 2025 | marketbeat.comOxford BioMedica touts strong first-half momentum ahead of meetingJune 11, 2025 | lse.co.ukOxford Biomedica (OTCMKTS:OXBDF) Trading 18.7% Higher - Here's What HappenedMay 31, 2025 | marketbeat.comOxford Biomedica plc (OTCMKTS:OXBDF) Sees Significant Growth in Short InterestMay 5, 2025 | marketbeat.comOxford Biomedica Full Year 2024 Earnings: EPS Beats ExpectationsMay 1, 2025 | finance.yahoo.comOxford Biomedica plc (OTCMKTS:OXBDF) Short Interest Up 83.5% in MarchApril 20, 2025 | marketbeat.comOxford BioMedica (OXBDF) Receives a Buy from RBC CapitalApril 15, 2025 | theglobeandmail.comWhen Will Oxford Biomedica plc (LON:OXB) Turn A Profit?April 10, 2025 | uk.finance.yahoo.comOxford Biomedica sees FY25 revenue GBP 160M-GBP 170MApril 9, 2025 | msn.comOxford Biomedica prepares statements on ‘going concern basis’April 9, 2025 | msn.comOxford Biomedica plc (OXBDF) Q4 2024 Earnings Call TranscriptApril 9, 2025 | seekingalpha.comOxford Biomedica annual loss narrows; hails "commercial momentum"April 9, 2025 | lse.co.ukOxford Biomedica plc (OTCMKTS:OXBDF) Short Interest Up 71.9% in MarchMarch 30, 2025 | marketbeat.comOxford Biomedica plc (OTCMKTS:OXBDF) Short Interest Up 131.0% in FebruaryMarch 14, 2025 | marketbeat.comOxford Biomedica plc (OTCMKTS:OXBDF) Sees Large Growth in Short InterestMarch 2, 2025 | marketbeat.comOxford Biomedica to support Boehringer Ingelheim’s LENTICLAIR 1 trialFebruary 20, 2025 | markets.businessinsider.comOxford Biomedica (OTCMKTS:OXBDF) Stock Price Down 0.9% - What's Next?February 10, 2025 | marketbeat.comOxford Biomedica appoints joint corporate broker, joint financial advisorFebruary 5, 2025 | markets.businessinsider.comOxford Biomedica Announces Total Voting Rights for 2024January 2, 2025 | markets.businessinsider.comOxford Biomedica plc (OTCMKTS:OXBDF) Short Interest UpdateDecember 26, 2024 | marketbeat.comOxford Biomedica Announces Total Voting RightsDecember 2, 2024 | markets.businessinsider.comOxford Biomedica Aligns Executive Incentives with GoalsNovember 23, 2024 | markets.businessinsider.comOxford Biomedica price target raised to 450 GBp from 305 GBp at JPMorganOctober 29, 2024 | markets.businessinsider.comOxford Biomedica Seeks Stock Market ExpansionOctober 22, 2024 | markets.businessinsider.comShort Interest in Oxford Biomedica plc (OTCMKTS:OXBDF) Drops By 66.7%October 10, 2024 | marketbeat.comRBC Capital Sticks to Its Buy Rating for Oxford BioMedica (OXBDF)September 27, 2024 | markets.businessinsider.comOxford BioMedica: A Strong Buy on Undervaluation and Promising Growth ProspectsSeptember 24, 2024 | markets.businessinsider.comOxford Biomedica posts strong revenue growth in first half resultsSeptember 23, 2024 | msn.comOxford Biomedica rebrands as OXB reinforcing transformation into leading global cell and gene therapy CDMOSeptember 18, 2024 | globenewswire.comLucinda Crabtree joins Oxford Biomedica as Chief Financial Officer todaySeptember 2, 2024 | globenewswire.comOxford Biomedica plc (OXBDF)August 18, 2024 | finance.yahoo.comOxford Biomedica – Half Year Trading Update and Notice of Interim ResultsAugust 8, 2024 | markets.businessinsider.com Get Oxford BioMedica News Delivered to You Automatically Sign up to receive the latest news and ratings for OXBDF and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. OXBDF Media Mentions By Week OXBDF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OXBDF News Sentiment▼0.000.70▲Average Medical News Sentiment OXBDF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OXBDF Articles This Week▼00▲OXBDF Articles Average Week Get the Latest News and Ratings for OXBDF and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Oxford BioMedica and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies ARWR News VKTX News XENE News KYMR News BVNRY News RARE News HCM News IMVT News KNSA News TARS News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:OXBDF) was last updated on 9/4/2025 by MarketBeat.com Staff From Our PartnersRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredNVIDIA's Worst Nightmare?$2 TRILLION Quantum Gold Rush While everyone fights over expensive AI stocks... McKinsey just revealed the ...The Oxford Club | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredFree: The Crypto Summit That Could Change Your Life27 industry leaders share urgent market intel (free access)... For a very limited time, you can claim your ...Crypto 101 Media | SponsoredThis Massive Market is Ripe for Disruption by this NasdaqFanatics Hit $31B. This Nasdaq Company Is Building the Next Wave Fanatics built a merch empire by owning th...i2i Marketing Group, LLC | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oxford BioMedica Please log in to your account or sign up in order to add this asset to your watchlist. Share Oxford BioMedica With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
